GRACEcast
Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to become informed partners in their care.
Visit Show Website http://cancerGRACE.org/Recently Aired
-
HD
ASCO Lung Cancer Highlights, Part 3: Immunotherapy for Stage III NSCLC (audio)
Dr. David Gerber, University of Texas-Southwestern, reviews results of the ...
Dr. David Gerber, University of Texas-Southwestern, reviews results of the START trial of tecemotide immunotherapy for stage III unresectable NSCLC.
-
HD
ASCO Lung Cancer Highlights, Part 2: Optimizing Radiation for Stage III NSCLC (video)
Dr. David Gerber, University of Texas-Southwestern, reviews results from RTOG ...
Dr. David Gerber, University of Texas-Southwestern, reviews results from RTOG 0617 that help clarify the optimal dose of radiation for stage III unresectable NSCLC.
-
HD
ASCO Lung Cancer Highlights, Part 2: Optimizing Radiation for Stage III NSCLC (audio)
Dr. David Gerber, University of Texas-Southwestern, reviews results from RTOG ...
Dr. David Gerber, University of Texas-Southwestern, reviews results from RTOG 0617 that help clarify the optimal dose of radiation for stage III unresectable NSCLC.
-
HD
ASCO Lung Cancer Highlights, Part 1: Introduction to Stage III NSCLC (video)
Dr. David Gerber, University of Texas-Southwestern, reviews the current questions ...
Dr. David Gerber, University of Texas-Southwestern, reviews the current questions in managing locally advanced NSCLC with chemo/radiation as introduction to key issues addressed in trials from ASCO 2013.
-
HD
ASCO Lung Cancer Highlights, Part 1: Introduction to Stage III NSCLC (audio)
Dr. David Gerber, University of Texas-Southwestern, reviews the current questions ...
Dr. David Gerber, University of Texas-Southwestern, reviews the current questions in managing locally advanced NSCLC with chemo/radiation as introduction to key issues addressed in trials from ASCO 2013.
-
HD
Dr. Bob Doebele: How Should We Manage Acquired Resistance with a Single Lesion or More Diffuse Progression?
Dr. Bob Doebele from the University of Colorado, offers his ...
Dr. Bob Doebele from the University of Colorado, offers his insights on how to approach a patient with gradual progression in a single site, especially in the brain, or more multifocal progression after a good initial response to a targeted agent.
-
HD
Dr. Philip Bonomi: Gefitinib and Later Generations of EGFR Inhibitors
Dr. Phil Bonomi, from Rush University, describes the generations of ...
Dr. Phil Bonomi, from Rush University, describes the generations of EGFR inhibitors beginning with Gefitinib (Iressa).
-
HD
Dr. David Spigel on "Which molecular marker tests do you seek?"
Dr. David Spigel, Sarah Cannon Cancer Center, describes which molecular ...
Dr. David Spigel, Sarah Cannon Cancer Center, describes which molecular markers he seeks for NSCLC patients.
-
HD
HPV in Head and Neck Cancer, Part 2: Caveats and Emerging Trials (video)
Dr. Jared Weiss from the University of North Carolina, Chapel ...
Dr. Jared Weiss from the University of North Carolina, Chapel Hill reviews results from HPV-positive patients with head and neck cancer (HNSCC) from recent trials and describes emerging research in this population.
-
HD
HPV in Head and Neck Cancer, Part 2: Caveats and Emerging Trials (audio)
Dr. Jared Weiss from the University of North Carolina, Chapel ...
Dr. Jared Weiss from the University of North Carolina, Chapel Hill reviews results from HPV-positive patients with head and neck cancer (HNSCC) from recent trials and describes emerging research in this population.
